NASDAQ:VTGN   Vistagen Therapeutics, Inc.
I like the consolidation over the past 2 weeks or so and the MACD cross that is about to happen. The price tested the .23 fib level several times but so far it has acted as resistance.

I would like to see a break of $2.79 with high relative volume to take a swing position.

Targets: $2.94, $3.05. $3.17, $3.34 and $3.55

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。